Sonal Singh to Cyclopropanes
This is a "connection" page, showing publications Sonal Singh has written about Cyclopropanes.
Connection Strength
0.060
-
Fain KM, Yu T, Li T, Boyd CM, Singh S, Puhan MA. Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations. J Clin Epidemiol. 2016 06; 74:151-7.
Score: 0.032
-
Yu T, Fain K, Boyd CM, Singh S, Weiss CO, Li T, Varadhan R, Puhan MA. Benefits and harms of roflumilast in moderate to severe COPD. Thorax. 2014 Jul; 69(7):616-22.
Score: 0.028